Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
Authors
Keywords
Herpes zoster, Postherpetic neuralgia, Vaccine, Cost-effectiveness, QALY, Markov
Journal
BMC HEALTH SERVICES RESEARCH
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-09-26
DOI
10.1186/1472-6963-13-359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natural history of herpes zoster: Late follow-up of 3.9 years (n = 43) and 7.7 years (n = 10)
- (2013) Haatem Reda et al. PAIN
- A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
- (2013) Thomas D. Szucs et al. PHARMACOECONOMICS
- Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
- (2013) Pieter T. de Boer et al. VACCINE
- Vaccination against herpes zoster and postherpetic neuralgia in France: a cost–effectiveness analysis
- (2013) Xavier Bresse et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules
- (2013) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
- (2012) Jorien GJ Pierik et al. BMC INFECTIOUS DISEASES
- Vom Zwang zur Pockenschutzimpfung zum Nationalen Impfplan
- (2012) S. Klein et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain
- (2011) Ana M Cebrián-Cuenca et al. BMC INFECTIOUS DISEASES
- Herpes zoster in Germany: Quantifying the burden of disease
- (2011) Bernhard Ultsch et al. BMC INFECTIOUS DISEASES
- The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
- (2011) Marc Brisson et al. Human vaccines & immunotherapeutics
- Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland
- (2011) Thomas D. Szucs et al. Human vaccines & immunotherapeutics
- Post-Shingles Neuralgia by Any Definition Is Painful, but Is It PHN?
- (2011) Barbara P. Yawn MAYO CLINIC PROCEEDINGS
- Herpes Zoster Recurrences More Frequent Than Previously Reported
- (2011) Barbara P. Yawn et al. MAYO CLINIC PROCEEDINGS
- Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium
- (2011) Joke Bilcke et al. VACCINE
- Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?
- (2011) Joke Bilcke et al. VACCINE
- Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
- (2010) Alies van Lier et al. BMC HEALTH SERVICES RESEARCH
- Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study
- (2010) Leonardo Emberti Gialloreti et al. BMC INFECTIOUS DISEASES
- The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study
- (2010) M. Drolet et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Varizellen und Herpes zoster
- (2010) Miriam Wittek et al. MEDIZINISCHE KLINIK
- Varizellen und Herpes zoster
- (2010) Miriam Wittek et al. MEDIZINISCHE KLINIK
- Herpes zoster: Burden of disease in France
- (2010) S. Gonzalez Chiappe et al. VACCINE
- Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium
- (2010) L. Annemans et al. JOURNAL OF MEDICAL ECONOMICS
- Cost Effectiveness of Herpes Zoster Vaccine in Canada
- (2009) Mehdi Najafzadeh et al. PHARMACOECONOMICS
- Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
- (2009) A.J. van Hoek et al. VACCINE
- Herpes Zoster and Postherpetic Neuralgia
- (2008) Robert W Johnson et al. DRUGS & AGING
- Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
- (2008) A. GAUTHIER et al. EPIDEMIOLOGY AND INFECTION
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine
- (2008) Kenneth Schmader et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination against Herpes Zoster and Postherpetic Neuralgia
- (2008) Michael N. Oxman et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now